Worldwide Prescription Drug & OTC Sales by Technology (2010-2024) part 2 of 2 Table 5: Worldwide Prescription Drug Sales from Biotechnology in 2024: Top 10 Companies Source: EvaluatePharma, May 2019 WW Sales ($bn) WW Market Share Rank Company 2018 2024 % CAGR 18-24 2018 2024 Chg. (+/-) Rank Chg. 1. Roche 37.5 38.7 +0.5% 15.4% 10.0% -5.4pp +0 2. Merck & Co 15.3 28.3 +10.9% 6.3% 7.3% +1.0pp +5 3. Sano昀椀 16.8 24.4 +6.4% 6.9% 6.3% -0.6pp +2 4. Amgen 19.2 21.5 +1.9% 7.9% 5.6% -2.3pp -1 5. Johnson & Johnson 16.0 20.9 +4.6% 6.6% 5.4% -1.2pp +1 6. Eli Lilly 12.8 19.8 +7.5% 5.3% 5.1% -0.2pp +2 7. Novo Nordisk 17.1 15.8 -1.3% 7.0% 4.1% -2.9pp -3 8. AbbVie 20.7 15.3 -4.9% 8.5% 3.9% -4.5pp -6 9. Bristol-Myers Squibb 11.2 15.1 +5.1% 4.6% 3.9% -0.7pp +0 10. P昀椀zer 11.0 14.5 +4.8% 4.5% 3.8% -0.8pp +0 Table 6: Worldwide Prescription Drug Sales from Top 100 Products Source: EvaluatePharma, May 2019 WW Sales ($bn) As a % Technology 2010 2018 2024 2010 2018 2024 Biologics 88 162 178 34% 53% 50% Small molecules 174 143 179 66% 47% 50% Total 262 306 357 100% 100% 100% 13 ® World Preview 2019 Copyright © 2019 Evaluate Ltd. All rights reserved. EvaluatePharma